NCT00003105View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 1997

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Interventions
BIOLOGICAL

filgrastim

DRUG

cisplatin

DRUG

doxorubicin hydrochloride

DRUG

gemcitabine hydrochloride

DRUG

ifosfamide

DRUG

paclitaxel

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003105 - Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer | Biotech Hunter | Biotech Hunter